HOWARD CHARLES, M.D.
Ophthalmology Physician · RYE, NY
Individual Active NPI 1427078310
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 2,068 | 33,337 | $4,094,343 | $3,819,782 | $2,977,695 |
| 2023 | 2,054 | 25,323 | $3,849,553 | $3,578,753 | $2,784,988 |
| 2022 | 2,150 | 17,646 | $4,172,087 | $3,929,954 | $3,061,263 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 17,280 | $35 | $27 |
| 92134 | Imaging of retina | 4,745 | $46 | $34 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 2,492 | $103 | $76 |
| J0178 | Injection, aflibercept, 1 mg | 2,070 | $826 | $658 |
| 67028 | Injection of drug into eye | 1,777 | $136 | $102 |
| 92014 | Established patient complete exam of visual system | 1,642 | $142 | $102 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 1,582 | $108 | $86 |
| J0177 | Injection, aflibercept hd, 1 mg | 411 | $330 | $263 |
| J2778 | Injection, ranibizumab, 0.1 mg | 383 | $162 | $128 |
| J9035 | Injection, bevacizumab, 10 mg | 293 | $72 | $56 |
| 92004 | New patient complete exam of visual system | 168 | $168 | $123 |
| 92250 | Photography of the retina | 120 | $42 | $32 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 150384-1 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New York
- NPI 1396714820
- NPI 1780856690
- NPI 1538153705
- NPI 1164000550
- NPI 1699971101
- NPI 1679237788
- NPI 1952845448
- NPI 1245863109
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.